Background image

Tremor Gram – October 2026

Posted on October 8, 2026

Barriers of Focused Ultrasound Treatment

What are the barriers to focused ultrasound treatment ablation (FUSA) for individuals who have essential tremor? Do they involve gender, ethnicity, socioeconomic factors? See what a study showed in our newest virtual education event, “Barriers of Focused Ultrasound for Essential Tremor.”

cover slide for the virtual education event titled Barriers of Focused Ultrasound Treatment for Essential Tremor

This event is presented by Dr. Vibhor Krishna, associate professor and vice chair of inpatient operations for the department of neurology at the University of North Carolina (UNC) School of Medicine, and Dr. Nicole Silva, chief resident, department of neurosurgery at UNC School of Medicine.

Here are a few results of the study:

  • Patients spend nearly a decade awaiting ET diagnosis and undergoing medical treatment from symptoms before undergoing surgical consultation for FUSA.
  • Women have significantly more provider consultations prior to their ET diagnosis.
  • Patients with lower socioeconomic status (less than $50,000) are more likely to have increased delay to diagnosis and delay to first consultation about FUSA.
  • Neurologist referral delay is longer for women compared to men.
  • Women reported more difficulty with hobbies and leisure.

A New Website is Coming

Graphic that says "A New Website is Coming" with a woman looking at a computer screen with the IETF website on it

We’ve been working on something exciting behind the scenes, and we’re almost ready to share it with you!

The IETF is preparing to launch a redesigned website, bringing together trusted information, practical resources and opportunities to connect with the ET community in a fresh, welcoming online experience.

Whether you’re looking for answers about essential tremor, exploring treatment options, searching for support or keeping up with the latest research, we want to make it easier to find what matters most to you.

The new website will feature improved navigation, expanded resource directories and easier access to educational materials, personal stories and support groups.

And while things may look a little different, one thing isn’t changing: our commitment to providing hope, support and resources to everyone affected by essential tremor.

Read our Latest Issue of Tremor Talk

Cover for the October 2026 issue of Tremor Talk magazine featuring a photo of support group leader Helen Moser posing with her 2026 Essential Tremor Awareness Month proclamation signed by the Connecticut governor

Our October issue of Tremor Talk magazine is in the mail. An online copy has been posted on our website, https://essentialtremor.org/news/tremor-talk/.

This issue includes a cover story about our Connecticut Essential Tremor (ET) Support

Group Leader Helen Moser, who has built one of the IETF’s largest ET support groups in the country. The issue also explores the global economic burden of ET. Elsa Unenge, founder of Breath Curriculum, explains how to use breathing as a tool for managing essential tremor. This issue also features our 10 Catherine Rice Scholarship recipients for 2026.

Tremor Talk is published three times a year: January, June and October. Hard copies of the 32-page magazine are mailed to donors. You can make a donation to be added to the mailing list.

Research Study Recruitment

Harmony Onsite Study

This is a research study taking place in person in Cupertino, CA. Participants who meet the study requirements will be invited to an onsite session where they will contribute to our research project.

artwork for clinical trials

What is the study about?

The purpose of the study is to collect health sensing data from adults to support the development, improvement and validation of products, such as devices, features, services, and algorithms.

Task Description:

If you agree to enroll in the study and are eligible, you will be asked to participate in a 2 hour in-person visit in Cupertino, CA. During your visit, you will be asked to wear medical-grade, non-invasive monitoring sensors on your chest and hold a smartphone while staying still for 30 seconds.

Who is eligible?

To participate you should meet the following qualifying criteria:

  • Be over 18 years old.  
  • Be fluent in English. 
  • Be able to visit the study location in Cupertino for a scheduled onsite session. 

Where is the study taking place?

This is an onsite study taking place at our premises in Cupertino, CA.

How much is the compensation?

  • $50 USD for completing the onsite screening.
  • $200 USD for successfully completing the onsite session.

How do I apply?

Interested individuals can review the study details and apply directly here:https://dataforcecommunity.transperfect.com/study/harmony-onsite-collection-us-cupertino?/fill?id313=DF035

PILOT Study of Essential Tremor
Dr. Elan Louis and his team of tremor researchers at UTSW Medical Center are conducting a new PILOT study of Essential Tremor (ET). They need help from the ET community. If you are at least 80 years old and have been diagnosed with essential tremor in the last 2 to 5 years, then please contact the UTSW researchers at the following email address: tremor@utsouthwestern.edu.

We are conducting a feasibility study during which we plan to contact you once and ask over the phone 10 questions, including age, gender, medication history, treatment received for ET, and location of tremor symptoms. After completing the screening, we will ask you if you would be interested in a future study.

Please include your contact information in your message, including your name, telephone and the time zone or state.

Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants with Upper Limb Essential Tremor
At Inland Northwest Research (INWR), we are enrolling adults with upper limb essential tremor (ET) for a Phase 2b clinical trial evaluating an investigational treatment called gemibotulinumtoxinA (AGN-151607-DP). The study will evaluate whether this investigational drug is safe and effective in reducing tremor. Approximately 94 participants will be enrolled at about 40 sites across the United States and Canada. Participants with INWR must be able to come to Spokane, Washington for appointments. 

Participants will receive injections of either the investigational treatment or a placebo and will complete questionnaires and clinical assessments over approximately 72 weeks. Following the blinded portion of the study, participants will have the opportunity to receive the investigational treatment during an open-label period.

Study Details:

Title:  A Phase 2b Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period to Evaluate the Efficacy and Safety of AGN-151607-DP (USAN: gemibotulinumtoxinA) for the Treatment of Upper Limb Essential Tremor in Adults

ID: M25-850
Estimated Enrollment: 94 participants
Start: June 2026
Estimated Study Completion: November 2028

Please note: Some study site information on ClinicalTrials.gov may not yet be up to date. If you are interested in participating, please contact us directly at contacts@inwresearch.com, visit our website at inwresearch.com, or contact the AbbVie Clinical Trials Call Center for the most current information on participating sites.

Syn-T: Analysis of Cutaneous Phosphorylated alpha-Synuclein to Identify Patients at Risk of Progressing from Essential Tremor to Parkinson’s Disease
Dr. Christopher Gibbons and his team at CND Life Sciences are conducting a new research study to identify Essential Tremor (ET) patients who may be at risk of developing Parkinson’s disease. If you are between 50-85 years old and have been diagnosed with essential tremor or essential tremor-plus, you may be eligible to participate.

This two-year observational study involves skin biopsies to detect phosphorylated α-synuclein, a biomarker that may indicate early Parkinson’s disease. Participants will undergo comprehensive neurological assessments and follow-up evaluations. Compensation of $250 per completed visit is provided.

The study is being conducted at select movement disorder and clinical research centers across the United States. Enrollment is available through participating sites only — patients must be seen at a study site to be eligible.

To find out if there is a participating site near you, please visit ClinicalTrials.gov and search for “Syn-T” or “essential tremor alpha-synuclein.” You may also email the study team at ClinicalResearch@CNDLifeSciences.com with your name, telephone number, age, and diagnosis information, and they will help connect you with a site in your area, if there is one close by,

Categories: Tremor Gram